Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 4Other solid neoplasm 3Tumor-Agnostic 2Gynecologic 2Genitourinary 2Gastrointestinal 2Breast 2Endocrine 1Dermatologic 1Classical hematology 1

Conditions

Ovarian Neoplasms 1Endometrial Neoplasms 1

Interventions

Paclitaxel 264Carboplatin 246Cisplatin 153Bevacizumab 104Gemcitabine 78Topotecan 77liposomal doxorubicin 67pembrolizumab 60Docetaxel 56Cyclophosphamide 50Taxes 48Radiotherapy 44olaparib 43Surveys and Questionnaires 43Doxorubicin 43Filgrastim 42Brachytherapy 37Drug Therapy 31niraparib 28Blood Specimen Collection 28Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 26human papillomavirus vaccine, L1 type 16, 18 24Peripheral Blood Stem Cell Transplantation 23atezolizumab 22Oxaliplatin 22Pemetrexed 21Nivolumab 21Hyperthermic Intraperitoneal Chemotherapy 21Etoposide 21Immunoglobulin G 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Rosuvastatin Calcium × Gynecologic × Clear all
NCT04491643 2025-08-11

Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma

Fudan University

Phase 2 Completed
48 enrolled
Gynecologic

Endometrial Neoplasms

NCT03532139 2025-01-23

Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study)

Beth Israel Deaconess Medical Center

Phase 2 Completed
24 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡